This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Cevec Pharmaceutical Gmbh. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: The Innovations of Markus Ribbert
Introduction
Markus Ribbert is a notable inventor based in Biberach an der Riss, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of glycoproteins. His work focuses on enhancing the properties of these proteins for various applications.
Latest Patents
Markus Ribbert holds a patent for "Recombinant glycoproteins with reduced antennary fucosylation." This invention relates to methods for reducing antennary fucosylation of complex N-glycans in recombinantly expressed glycoproteins. It also includes cell lines that can be utilized in these methods, as well as the respective recombinant glycoproteins and methods for expressing them in said cell lines. He has 1 patent to his name.
Career Highlights
Throughout his career, Ribbert has worked with various companies, including Cevec Pharmaceutical GmbH and Cevec Pharmaceuticals GmbH. His expertise in biotechnology has allowed him to contribute to advancements in the field.
Collaborations
Some of his notable coworkers include Hanns-Martin Schmidt and Gudrun Schiedner. Their collaboration has likely fostered innovation and development in their respective projects.
Conclusion
Markus Ribbert's work in recombinant glycoproteins showcases his innovative spirit and dedication to advancing biotechnology. His contributions are valuable to the scientific community and have the potential to impact various industries.